BlueTree Venture Fund

BlueTree Venture Fund is a venture capital firm that targets early institutional investments in sectors, which both match the region’s technology platform and leverage the expertise within its fund. The firm seeks to invest in medical technologies, software, and high-tech instrumentation companies located within 250 miles, allowing it to provide hands-on mentorship and guidance. Within these sectors, BlueTree Venture is interested in companies demonstrating compelling technologies, strong management teams, and capital-efficient business models with clear opportunities for exit through strategic acquisition.

Roger Byford

Managing Partner

David Motley

Managing Partner

Jon Pastor

Venture Partner

3 past transactions

Instant Teams

Series A in 2022
Instant Teams, Inc. operates a remote workforce supplier and management platform designed to connect companies with untapped talent pools. The company's platform, known as Arti, allows hiring managers to define their talent needs and timelines, facilitating the matching of pre-qualified, native English-speaking professionals to various projects. In addition to talent sourcing, Instant Teams offers a comprehensive management platform that includes features for payroll, compliance, time tracking, and reporting. The company is particularly focused on supporting the military community and has established partnerships with the Department of Defense to place skilled professionals who often have transient lifestyles. Founded in 2016 and based in Rehoboth Beach, Delaware, Instant Teams aims to enhance the future of remote work by providing businesses access to agile marketing, administrative, and operational talent.

Peptilogics

Series A in 2017
Peptilogics is developing eCAP technology, a propriety platform with preclinical effectiveness against resistant bacteria and biofilms. The company is dedicated to developing a new class of broad-spectrum antibiotics to address the epidemic of multidrug-resistant bacterial infections. Peptilogics is a preclinical biotechnology company with demonstrated preclinical in vitro and in vivo effectiness against the priority resistant pathogens.

Iteros

Series A in 2017
Iteros is an energy software company that models, controls and manages sustainable energy systems by optimizing distributed generation, energy storage, and other complementary distributed energy resource technologies. It provides an end-to-end software platform with modules for modeling and simulation, monitoring and visualization, and controls/management, enabling their customers to develop a comprehensive energy strategy to maximize profitability and reduce energy spend.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.